Jonathan Fallowfield

Medicine & Life Sciences

1. Fibrosis 100%
2. Liver Cirrhosis 82%
3. Liver 51%
4. Liver Diseases 34%
5. Relaxin 34%
6. Portal Hypertension 31%
7. Multiparametric Magnetic Resonance Imaging 31%
8. Coffee 30%
9. Non-alcoholic Fatty Liver Disease 28%
10. Fatty Liver 26%
11. Type 2 Diabetes Mellitus 25%
12. Hepatorenal Syndrome 24%
13. Biomarkers 24%
14. Macrophages 16%
15. Hepatic Stellate Cells 15%
16. Myofibroblasts 14%
17. Meta-Analysis 13%
18. Vasodilator Agents 12%
19. Cicatrix 12%
20. Kidney 12%
21. Hepatocellular Carcinoma 12%
22. Chronic Disease 11%
23. Therapeutics 11%
24. relaxin receptors 11%
25. Theoretical Models 10%
26. Elastin 10%
27. Systematic Reviews 9%
28. Portal Pressure 8%
29. Fats 8%
30. Biopsy 8%
31. Cohort Studies 7%
32. Renal Circulation 7%
33. Randomized Controlled Trials 7%
34. Genome-Wide Association Study 7%
35. Multicenter Studies 7%
36. Hemodynamics 7%
37. Protons 7%
38. Cardiovascular Diseases 6%
39. Matrix Metalloproteinase 12 6%
40. Health 6%
41. Mortality 6%
42. Safety 6%
43. Keratin-18 5%
44. Feasibility Studies 5%
45. Matrix Metalloproteinase 13 5%
46. Synthetic Drugs 5%
47. Elasticity Imaging Techniques 5%
48. Placebos 5%
49. Peptide Receptors 5%
50. Venous Pressure 5%